GI Rollover Equity in Private Equity Deals Explained
GI rollover equity is the portion of a gastroenterologist’s sale proceeds that is reinvested in the buyer’s platform instead of being paid in cash at closing. In most private equity transactions involving gastroenterology groups, selling physicians are asked to roll over part of their value, which makes them shareholders in the larger organization.
Rollover equity is often described as the “second bite of the apple,” because physicians may receive another payment if the platform is later sold. Whether that second bite turns out to be meaningful depends on many factors outside any one physician’s control. This article explains how rollover equity generally works and what physicians should ask. It is general information only; nothing here is legal, tax, investment or securities advice, and owners should rely on healthcare counsel, tax advisors and other qualified professionals.
What GI Rollover Equity Is
When an investor-backed group buys a GI practice, the purchase price is typically paid in a mix of forms:
- Cash at closing: paid to selling physicians when the deal closes
- Rollover equity: ownership in the platform or a holding company, in place of some cash
- Contingent payments: in some deals, earnouts or deferred amounts tied to future performance
Rollover equity aligns the physicians’ interests with the investor’s. If the platform grows and is later sold at a higher value, the rolled equity may be worth more than when it was received. If the platform struggles, it may be worth less, or very little.
Why Investors Ask for Rollover
From the investor’s perspective, rollover equity:
- Reduces the cash needed at closing
- Keeps physicians invested in the platform’s success
- Signals to lenders and future buyers that physicians believe in the business
- Encourages physicians to stay and help integrate future acquisitions
The amount of rollover requested varies by deal and is negotiated. Some groups push for more cash and less rollover, while others accept more rollover in exchange for other terms.
The Second Bite: How It Can Work
Private equity groups generally plan to sell their platforms after a holding period. When that happens, rollover holders may receive proceeds based on the value of their shares at that time. Some physicians may roll part of those proceeds again into the next owner’s platform.
Several factors influence whether the second bite is attractive:
- How much the platform grows earnings during the holding period
- How much debt the platform carries, since debt is repaid before equity holders
- The market for healthcare transactions at the time of exit
- The class of shares physicians hold and their rights compared with the investor’s
- Management fees, preferred returns or other terms that come before common equity
Because these factors are uncertain, physicians should treat projected second-bite values as possibilities, not promises.
Key Terms to Review
The value of GI rollover equity depends heavily on the documents. Physicians should understand:
- Share class: whether rollover shares are the same class as the investor’s or a different class with different rights
- Liquidation preferences: whether other investors are paid first in a sale
- Dilution: how future acquisitions and new investment may reduce your percentage ownership
- Vesting and forfeiture: whether shares can be lost if you leave early or violate a covenant
- Repurchase rights: whether the company can buy back your shares, and at what price, when you depart
- Tag-along and drag-along rights: how your shares are treated when the investor sells
- Information rights: what financial reporting you will receive as a minority holder
These provisions can affect value as much as the headline price. Healthcare and corporate counsel should review them before signing.
Tax Considerations
Rollover equity may be structured so that some taxes are deferred until the shares are sold, but that depends on how the transaction is organized and on current tax law. Physicians should work with tax advisors early, since structure is often set in the letter of intent and hard to change later.
How Rollover Fits Into the Whole Deal
Rollover equity is only one part of the economics. Physicians should also weigh the post-sale compensation reset, employment terms, restrictive covenants and what happens to endoscopy center and real estate interests. A sale that looks attractive on rollover projections may still reduce long-term income, especially for younger physicians.
Our article on gastroenterology private equity walks through the broader decision, and our guide to gastroenterology practice valuation explains how value is set in the first place.
Questions Physicians Commonly Ask
- Can I choose how much to roll over, or is it set for all sellers?
- Can my rollover shares be sold before the platform is sold?
- What happens to my shares if I retire, become disabled or leave?
- Will my shares be diluted as the platform acquires more practices?
- How will I know what my shares are worth along the way?
Comparing Rollover With Independent Options
Some groups decide that the uncertainty of rollover is not worth the loss of control. Physicians who want liquidity while staying independent may consider an internal buyout or a bank recapitalization. Our guide to an alternative to private equity explains how that may work, and middle-market healthcare financing may support larger recapitalizations and partner buyouts, subject to lender review and approval.
Owners preparing for any transaction may also benefit from our advisory and consulting services, which can help evaluate offers and alternatives.
Final Thoughts
GI rollover equity can add value to a private equity transaction, but it is an investment with real risk. Understanding share classes, preferences, dilution and repurchase terms, and weighing rollover against the full deal and independent alternatives, can help physicians make a decision that fits their goals.
US Medical Funding helps independent gastroenterology groups explore financing for recapitalizations, partner buyouts and growth. Learn more about our gastroenterology practice financing options.
